Helios As a Potential Biomarker in Systemic Lupus Erythematosus and New Therapies Based on Immunosuppressive Cells

Overview

Journal Int J Mol Sci

Publisher MDPI

Specialties Biochemistry
Chemistry
Molecular Biology

Date 2024 Jan 11

PMID 38203623

Authors

Andres Paris-Munoz

Odelaisy Leon-Triana

Antonio Perez-Martinez

Domingo F Barber

Affiliations

Soon will be listed here.

Abstract

The Helios protein (encoded by the gene) is a member of the Ikaros transcription family and it has recently been proposed as a promising biomarker for systemic lupus erythematosus (SLE) disease progression in both mouse models and patients. Helios is beginning to be studied extensively for its influence on the T regulatory (Treg) compartment, both CD4 Tregs and KIR/Ly49 CD8 Tregs, with alterations to the number and function of these cells correlated to the autoimmune phenomenon. This review analyzes the most recent research on Helios expression in relation to the main immune cell populations and its role in SLE immune homeostasis, specifically focusing on the interaction between T cells and tolerogenic dendritic cells (tolDCs). This information could be potentially useful in the design of new therapies, with a particular focus on transfer therapies using immunosuppressive cells. Finally, we will discuss the possibility of using nanotechnology for magnetic targeting to overcome some of the obstacles related to these therapeutic approaches.

Citing Articles

Natural Killer Cells and Cytotoxic T Cells: Complementary Partners against Microorganisms and Cancer.

Vojdani A, Koksoy S, Vojdani E, Engelman M, Benzvi C, Lerner A Microorganisms. 2024; 12(1).

PMID: 38276215 PMC: 10818828. DOI: 10.3390/microorganisms12010230.

References

Plitas G, Rudensky A . Regulatory T Cells: Differentiation and Function. Cancer Immunol Res. 2016; 4(9):721-5. PMC: 5026325. DOI: 10.1158/2326-6066.CIR-16-0193. View

Mayer C, Floess S, Baru A, Lahl K, Huehn J, Sparwasser T . CD8+ Foxp3+ T cells share developmental and phenotypic features with classical CD4+ Foxp3+ regulatory T cells but lack potent suppressive activity. Eur J Immunol. 2011; 41(3):716-25. DOI: 10.1002/eji.201040913. View

Pisetsky D, Lipsky P . New insights into the role of antinuclear antibodies in systemic lupus erythematosus. Nat Rev Rheumatol. 2020; 16(10):565-579. PMC: 8456518. DOI: 10.1038/s41584-020-0480-7. View

Ding D, Mehta H, McCune W, Kaplan M . Aberrant phenotype and function of myeloid dendritic cells in systemic lupus erythematosus. J Immunol. 2006; 177(9):5878-89. DOI: 10.4049/jimmunol.177.9.5878. View

Satooka H, Nagakubo D, Sato T, Hirata T . The ERM Protein Moesin Regulates CD8 Regulatory T Cell Homeostasis and Self-Tolerance. J Immunol. 2017; 199(10):3418-3426. DOI: 10.4049/jimmunol.1700074. View

Moulton V, Tsokos G . T cell signaling abnormalities contribute to aberrant immune cell function and autoimmunity. J Clin Invest. 2015; 125(6):2220-7. PMC: 4497749. DOI: 10.1172/JCI78087. View

Li H, Adamopoulos I, Moulton V, Stillman I, Herbert Z, Moon J . Systemic lupus erythematosus favors the generation of IL-17 producing double negative T cells. Nat Commun. 2020; 11(1):2859. PMC: 7275084. DOI: 10.1038/s41467-020-16636-4. View

Vignali D, Collison L, Workman C . How regulatory T cells work. Nat Rev Immunol. 2008; 8(7):523-32. PMC: 2665249. DOI: 10.1038/nri2343. View

Fiore N, Castellano G, Blasi A, Capobianco C, Loverre A, Montinaro V . Immature myeloid and plasmacytoid dendritic cells infiltrate renal tubulointerstitium in patients with lupus nephritis. Mol Immunol. 2007; 45(1):259-65. DOI: 10.1016/j.molimm.2007.04.029. View

10.

Josefowicz S, Lu L, Rudensky A . Regulatory T cells: mechanisms of differentiation and function. Annu Rev Immunol. 2012; 30:531-64. PMC: 6066374. DOI: 10.1146/annurev.immunol.25.022106.141623. View

11.

Grant C, Liberal R, Mieli-Vergani G, Vergani D, Longhi M . Regulatory T-cells in autoimmune diseases: challenges, controversies and--yet--unanswered questions. Autoimmun Rev. 2014; 14(2):105-16. DOI: 10.1016/j.autrev.2014.10.012. View

12.

Schmidt A, Oberle N, Krammer P . Molecular mechanisms of treg-mediated T cell suppression. Front Immunol. 2012; 3:51. PMC: 3341960. DOI: 10.3389/fimmu.2012.00051. View

13.

Eberl G, Pradeu T . Towards a General Theory of Immunity?. Trends Immunol. 2017; 39(4):261-263. DOI: 10.1016/j.it.2017.11.004. View

14.

Kurts C, Heath W, Kosaka H, Miller J, Carbone F . The peripheral deletion of autoreactive CD8+ T cells induced by cross-presentation of self-antigens involves signaling through CD95 (Fas, Apo-1). J Exp Med. 1998; 188(2):415-20. PMC: 2212451. DOI: 10.1084/jem.188.2.415. View

15.

Lin S, Chen K, Lin C, Kuo C, Ling Q, Chan C . The quantitative analysis of peripheral blood FOXP3-expressing T cells in systemic lupus erythematosus and rheumatoid arthritis patients. Eur J Clin Invest. 2007; 37(12):987-96. DOI: 10.1111/j.1365-2362.2007.01882.x. View

16.

Steinbrink K, Graulich E, Kubsch S, Knop J, Enk A . CD4(+) and CD8(+) anergic T cells induced by interleukin-10-treated human dendritic cells display antigen-specific suppressor activity. Blood. 2002; 99(7):2468-76. DOI: 10.1182/blood.v99.7.2468. View

17.

Pita R, Ehmann F, Papaluca M . Nanomedicines in the EU-Regulatory Overview. AAPS J. 2016; 18(6):1576-1582. DOI: 10.1208/s12248-016-9967-1. View

18.

Accapezzato D, Caccavale R, Paroli M, Gioia C, Nguyen B, Spadea L . Advances in the Pathogenesis and Treatment of Systemic Lupus Erythematosus. Int J Mol Sci. 2023; 24(7). PMC: 10095030. DOI: 10.3390/ijms24076578. View

19.

Onishi Y, Fehervari Z, Yamaguchi T, Sakaguchi S . Foxp3+ natural regulatory T cells preferentially form aggregates on dendritic cells in vitro and actively inhibit their maturation. Proc Natl Acad Sci U S A. 2008; 105(29):10113-8. PMC: 2481354. DOI: 10.1073/pnas.0711106105. View

20.

Feuerer M, Herrero L, Cipolletta D, Naaz A, Wong J, Nayer A . Lean, but not obese, fat is enriched for a unique population of regulatory T cells that affect metabolic parameters. Nat Med. 2009; 15(8):930-9. PMC: 3115752. DOI: 10.1038/nm.2002. View